Central Blood Pressure and Pulse Wave Velocity in Kidney Transplant Recipients
Public ClinicalTrials.gov record NCT04212143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Central Blood Pressure and Pulse Wave Velocity in Children With and Without Kidney Transplants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An observational cohort study will be conducted to non-invasively investigate central blood pressure and pulse wave velocity in children with kidney disease and controls. Using an oscillometric monitor, the investigators aim to non-invasively obtain the central blood pressure and pulse wave velocity (PWV), or arterial stiffness, of children with kidney disease. The investigators will also enroll age- and race-matched healthy controls and measure the same parameters for comparison. In addition, the investigators will measure PWV by standard arterial tonometry method in a subset of patients.
Study identification
- NCT ID
- NCT04212143
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2021
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
- Last update posted
- Jul 2, 2025
2021 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's National Medical Cetner | Washington D.C. | District of Columbia | 20010 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated End Stage Renal Disease trials
Other public records listing End Stage Renal Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT04163614: Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients Recruiting
- NCT06516653: Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula Recruiting
- NCT07696962: Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease Not yet recruiting
- NCT04392206: AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses Recruiting
- NCT03674307: Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates Active, not recruiting
- NCT06422871: PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04212143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2025 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04212143 live on ClinicalTrials.gov.